Pharmally International Holding Company Limited

6452

KYG7060F1019

Pharmally International Holding Company Limited announces an Equity Buyback for 2,000,000 shares, representing 3.08% for TWD 1,871.54 million.

May 13, 2015 at 11:03 am

Pharmally International Holding Company Limited (GTSM:6452) announces a share repurchase program. Under the plan, the company will repurchase up to 2,000,000 shares, representing 3.08 % stake for TWD 1,871.54 million. The shares will be repurchased in a price range of TWD 150 per share to TWD 200 per share.

The repurchase program will be valid till July 13, 2015.

Latest news about Pharmally International Holding Company Limited

Pharmally International Holding Company Limited(TSEC:6452) dropped from S&P Global BMI Index	30/09/20	CI
Pharmally International Holding Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	13/05/20	CI
Pharmally International Holding Company Limited Reports Earnings Results for the Full Year Ended December 31, 2019	30/03/20	CI
Pharmally International Holding Company Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019	13/11/19	CI
Pharmally International Holding Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019	13/08/19	CI
Pharmally International Holding Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2019	14/05/19	CI
Pharmally International Holding Co Ltd Reports Earnings Results for the Full Year Ended December 31, 2018	21/03/19	CI
Pharmally International Holding Company Limited announced that it has received TWD 1.17 billion in funding	26/11/17	CI
Pharmally International Holding Company Limited completed the acquisition of PT. Biotis Prima Agrisindo.	30/07/16	CI
Pharmally International Holding Company Limited agreed to acquire PT. Biotis Prima Agrisindo for zero consideration.	11/07/16	CI
Pharmally International Holding Company Limited(TSEC:6452) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index	01/12/15	CI
Pharmally International Holding Company Limited(TSEC:6452) added to S&P Global BMI Index	21/09/15	CI
Pharmally International Holding Company Limited's Equity Buyback announced on May 13, 2015 has expired.	12/07/15	CI
Pharmally International Holding Company Limited(TSEC:6452) added to Russell Global Index	29/06/15	CI
Pharmally International Holding Company Limited(TSEC:6452) added to Taiwan TAIEX Index	12/06/15	CI
Pharmally International Holding Company Limited announces an Equity Buyback for 2,000,000 shares, representing 3.08% for TWD 1,871.54 million.	13/05/15	CI
Pharmally International Holding Company Limited authorizes a Buyback Plan.	12/05/15	CI

Chart Pharmally International Holding Company Limited

Duration

Period

Chart Pharmally International Holding Company Limited

More charts

Company Profile

Pharmally International Holding Co Ltd is a Taiwan-based company primarily engaged in the production and sale of large volume injection and active pharmaceutical ingredients. It primarily produces large volume injection, including glass bottles, plastic bottles and non-polyvinyl chloride soft bags, and active pharmaceutical ingredients, such as nikethamide and levofloxacin lactate. It products sites are based in Mainland China.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+17.45%	42.25B
OTSUKA HOLDINGS CO., LTD.	+15.37%	21.27B
SANDOZ GROUP AG	+19.33%	15.23B
CIPLA LIMITED	+19.20%	14.36B
ZYDUS LIFESCIENCES LIMITED	+50.97%	12.74B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.40%	6.61B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.28%	5.66B

Generic Pharmaceuticals